Technical Analysis for KRYS - Krystal Biotech, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Up | Up | Down |
| Historical KRYS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| MACD Bearish Signal Line Cross | Bearish | 0.00% | |
| New Downtrend | Bearish | 0.00% | |
| Stochastic Sell Signal | Bearish | 0.00% | |
| Non-ADX 1,2,3,4 Bullish | Bullish Swing Setup | 0.00% | |
| Wide Range Bar | Range Expansion | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Overbought Stochastic | Strength | -13.91% | |
| Jack-in-the-Box Bullish | Bullish Swing Setup | -14.98% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| Down 2 ATRs | about 5 hours ago | |
| Fell Below 20 DMA | about 5 hours ago | |
| Down 10% | about 6 hours ago | |
| 20 DMA Support | about 7 hours ago | |
| Down 1 ATR | about 8 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 09/27/2019
Krystal Biotech, Inc. Description
Krystal Biotech, Inc. gene therapy company. The Company is engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. The Company has developed a Skin TARgeted Delivery platform, or STAR-D platform, that consists of a patent pending engineered viral vector based on herpes simplex virus 1, or HSV-1, and skin-optimized gene transfer technology, to develop off-the-shelf treatments for dermatological diseases. The Company’s products include KB103 and KB104.The Compnay's KB103 is in preclinical development to treat dystrophic epidermolysis bullosa, or DEB, a rare and severe genetic disease. The Compnay's KB104 is to treat Netherton Syndrome, a severe form of ichthyosis, which is a family of genetic skin disorders associated with thickened scaly skin and characterized by chronic skin inflammation, itchiness, dehydration and stunted growth.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Clinical Medicine Clinical Development Rare Diseases Inflammation Gene Therapy Genetic Disease Herpes Genodermatoses Herpes Simplex Herpes Simplex Virus Dehydration Epidermolysis Bullosa Dermatological Diseases Ichthyosis Itchiness Netherton Syndrome Skin Inflammation
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 87.025 |
| 52 Week Low | 33.0848 |
| Average Volume | 155,597 |
| 200-Day Moving Average | 51.94 |
| 50-Day Moving Average | 69.42 |
| 20-Day Moving Average | 75.26 |
| 10-Day Moving Average | 79.40 |
| Average True Range | 5.17 |
| ADX | 26.27 |
| +DI | 22.05 |
| -DI | 23.22 |
| Chandelier Exit (Long, 3 ATRs ) | 71.52 |
| Chandelier Exit (Short, 3 ATRs ) | 77.89 |
| Upper Bollinger Band | 85.83 |
| Lower Bollinger Band | 64.69 |
| Percent B (%b) | 0.33 |
| BandWidth | 28.09 |
| MACD Line | 3.29 |
| MACD Signal Line | 3.44 |
| MACD Histogram | -0.1442 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 92.79 | ||||
| Resistance 3 (R3) | 94.89 | 89.94 | 89.26 | ||
| Resistance 2 (R2) | 89.94 | 84.56 | 88.89 | 88.09 | |
| Resistance 1 (R1) | 80.80 | 81.24 | 78.33 | 78.70 | 86.91 |
| Pivot Point | 75.85 | 75.85 | 74.62 | 74.80 | 75.85 |
| Support 1 (S1) | 66.71 | 70.47 | 64.24 | 64.61 | 56.39 |
| Support 2 (S2) | 61.76 | 67.15 | 60.71 | 55.21 | |
| Support 3 (S3) | 52.62 | 61.76 | 54.04 | ||
| Support 4 (S4) | 50.52 |
